THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 118 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 7.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,414,000 | -60.1% | 1,370,250 | -57.9% | 0.22% | -55.4% |
| Q1 2022 | $31,115,000 | -52.9% | 3,254,713 | -45.5% | 0.50% | -40.5% |
| Q4 2021 | $66,019,000 | +51.3% | 5,974,535 | +1.3% | 0.85% | +77.2% |
| Q3 2021 | $43,624,000 | -34.2% | 5,895,159 | +29.2% | 0.48% | -28.5% |
| Q2 2021 | $66,270,000 | -47.8% | 4,564,045 | -26.6% | 0.67% | -43.6% |
| Q1 2021 | $126,932,000 | +14.9% | 6,219,110 | 0.0% | 1.19% | +22.8% |
| Q4 2020 | $110,514,000 | +20.2% | 6,219,110 | 0.0% | 0.97% | -16.3% |
| Q3 2020 | $91,950,000 | +71.5% | 6,219,110 | +143.5% | 1.16% | +53.1% |
| Q2 2020 | $53,618,000 | +996.7% | 2,554,470 | +1107.5% | 0.76% | +820.7% |
| Q1 2020 | $4,889,000 | – | 211,545 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |